This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Voyager Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dillon Kavanagh: Innovator in Tau Binding Compounds
Introduction
Dillon Kavanagh is a notable inventor based in Cambridge, MA. He has made significant contributions to the field of biotechnology, particularly in the development of tau binding compounds. With a total of 2 patents to his name, Kavanagh is recognized for his innovative work in this specialized area.
Latest Patents
Kavanagh's latest patents focus on tau binding compounds, which are crucial in the study and treatment of neurodegenerative diseases. These compounds have the potential to advance therapeutic strategies and improve patient outcomes.
Career Highlights
Dillon Kavanagh is currently employed at Voyager Therapeutics, Inc., a company dedicated to developing gene therapies for neurological diseases. His work at Voyager Therapeutics has positioned him as a key player in the biotechnology sector.
Collaborations
Kavanagh collaborates with talented individuals such as Todd Carter and Wencheng Liu. These partnerships enhance the innovative capacity of their projects and contribute to the advancement of their research.
Conclusion
Dillon Kavanagh's contributions to the field of biotechnology, particularly through his patents on tau binding compounds, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of neurodegenerative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile